EC Paediatrics

Short Communication Volume 13 Issue 6 - 2025

RNAi Technique for Vascular Malfunction Therapy in Arterial Hypertension and Diabetes: Fact or Fancy?

Anatoly Ivan Soloviev*

Institute of Pharmacology and Toxicology, National Academy of Medical Science, Kyiv, Ukraine

*Corresponding Author: Anatoly Ivan Soloviev, Institute of Pharmacology and Toxicology, National Academy of Medical Science, Kyiv, Ukraine.
Received: May 20, 2025; Published: June 03, 2025



Arterial hypertension and diabetes are well known as complex syndromes which lead to multiple malfunctions including fatal vascular contractile abnormalities. Changes in potassium conductance, endothelium-dependent relaxation and myofilament Ca2+ - sensitivity play a crucial role in interplay in contraction/dilation mechanisms of vascular smooth muscle (SM) cells in both hypertension and diabetes. High level of protein kinase C (PKC) activity is appears to be a common feature for hypertension states of different genesis and diabetic vascular disease. We have studied the effectiveness of the RNA interference (RNAi) technique which is able targeting PKC delta-isoform gene and this way to restore vasodilator potential in both spontaneously hypertensive (SHR) and diabetic rats (DR). Experimental design of this study comprised RNAi and patch-clamp techniques in whole-cell configuration, RT-PCR analysis and standard acetylcholine (Ach) test.

Anatoly Ivan Soloviev. "RNAi Technique for Vascular Malfunction Therapy in Arterial Hypertension and Diabetes: Fact or Fancy?". EC Paediatrics 13.6 (2025): 01-02.